These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A dramatic, objective antiandrogen withdrawal response: case report and review of the literature.
    Author: Lau YK, Chadha MK, Litwin A, Trump DL.
    Journal: J Hematol Oncol; 2008 Nov 05; 1():21. PubMed ID: 18986533.
    Abstract:
    Antiandrogen withdrawal response is an increasingly recognized entity in patients with metastatic prostate cancer. To our knowledge, there have been no reports describing a durable radiologic improvement along with prostate-specific antigen (PSA) with discontinuation of the antiandrogen agent bicalutamide. We report a case in which a dramatic decline of serum PSA levels associated with a dramatic improvement in radiologic disease was achieved with bicalutamide discontinuation.
    [Abstract] [Full Text] [Related] [New Search]